DLL3 (G93) AntibodyProduct information
Product Pathways - Development
DLL3 (G93) Antibody #2483
|2483S||100 µl (10 western blots)||---||In Stock||---|
|2483T||20 µl (2 western blots)||---||In Stock||---|
|2483||carrier free and custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Species predicted to react based on 100% sequence homology: Mouse.
Specificity / Sensitivity
DLL3 (G93) Antibody detects transfected levels of DLL3. It does not recognize transfected levels of rat DLL1 and human DLL4.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to a region surrounding residue Gly93 of mouse DLL3. Antibodies are purified by protein A and peptide affinity chromatography.
Notch signaling is activated upon engagement of the Notch receptor with its ligands, the DSL (Delta, Serrate, Lag2) proteins of single-pass type I membrane proteins. The DSL proteins contain multiple EGF-like repeats and a DSL domain that is required for binding to Notch (1,2). Five DSL proteins have been identified in mammals: Jagged1, Jagged2, Delta-like (DLL) 1, 3 and 4 (3). Ligand binding to the Notch receptor results in two sequential proteolytic cleavages of the receptor by the ADAM protease and the γ-secretase complex. The intracellular domain of Notch is released and then translocates to the nucleus where it activates transcription. Notch ligands may also be processed in a way similar to Notch, suggesting a bi-directional signaling through receptor-ligand interactions (4-6).
Mutations in DLL3 cause Spondylocostal dysostoses (SCD), a diverse group of disorders of axial skeletal malformation (7-10).
- Wilson, A. and Radtke, F. (2006) FEBS Lett. 580, 2860-2868.
- Hansson, E.M. et al. (2004) Semin. Cancer Biol. 14, 320-328.
- Chiba, S. (2006) Stem Cells 24, 2437-2447.
- Bland, C.E. et al. (2003) J. Biol. Chem. 278, 13607-13610.
- Six, E. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 7638-7643.
- LaVoie, M.J. and Selkoe, D.J. (2003) J. Biol. Chem. 278, 34427-34437.
- Whittock, N.V. et al. (2004) Clin. Genet. 66, 67-72.
- Turnpenny, P.D. et al. (2003) J. Med. Genet. 40, 333-339.
- Bulman, M.P. et al. (2000) Nat. Genet. 24, 438-441.
- Bonafé, L. et al. (2003) Clin. Genet. 64, 28-35.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 4147 Cleaved Notch1 (Val1744) (D3B8) Rabbit mAb
- 2155 Jagged1 (1C4) Rabbit mAb
- 2620 Jagged1 (28H8) Rabbit mAb
- 2210 Jagged2 (C23D2) Rabbit mAb
- 2205 Jagged2 (C83A8) Rabbit mAb
- 4608 MAML1 Antibody
- 4618 MAML2 Antibody
- 3608 Notch1 (D1E11) XP® Rabbit mAb
- 2423 Notch4 (L5C5) Mouse mAb
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.